Institute for Medical Informatics, Statistics and Epidemiology (IMISE)

This project covers the bachelor's and master's theses of the MAGIS working group.

“Inclusion health is a service, research, and policy agenda that aims to prevent and redress health and social inequities among the most vulnerable and excluded populations”. [1] Medical informatics shall help improving care for people pushed to the margins of society. We use the term “Inclusion Health Informatics” to identify this area of multidisciplinary research bringing together expertise from medical informatics, medicine, psychiatry, ethics, social work and other social sciences. Inclusion ...

The group is interested in omic-level studies including the genome, methylome, transcriptome, and metabolome of the general population as well as of various diseases including cardiovascular diseases, pneumonia, sepsis, obesity, and brain cancers. Additionally, we aim at transfering results of biomathematical model simulations into clinical practice e.g. by haematopoietic growth-factor opimization during cytotoxic chemotherapy and optimization of EPO applications in chronic kidney disease.

The ...

The aim of the project is to use methods and processes of the Medical Informatics Initiative (MII) to contribute to the detection of health risks in patients with polypharmacy. Polypharmacy occurs especially in elderly patients with multimorbidity. Polypharmacy associated with an increased risk for medication errors and drug-drug or drug-disease interactions, which either reduce or intensify the desired effect of individual active substances or lead to undesired adverse drug effects (ADE). In the ...

The software components of this project are available under "Related Items" > "Models".

Open-Science-Lehrmaterialien für die Medizininformatik basierend auf Werkzeugen und Diensten von NFDI4Health

Project for testing requests and functions of LHA

Rare diseases (RD) occur with a prevalence of less than 1:2,000 persons (EU definition). More than 8,000 RD are known, often genetically determined. Due to their rare occurrence, the RD are often not diagnosed at all, incorrectly or with a long delay diagnosed. Medical experts are mainly involved in selected Centers for Rare Diseases available.The goal of the LEUKO-Expert project is to establish an expert system for the diagnostic support of RD Leukodystrophy and to evaluate it within the scope ...